$Atea Pharmaceuticals, Inc.(AVIR)$

AT-527 

Phase 1 - March 21 (Successful)

Phase 2 - Oct 21 (Failure)

Phase 3 - Jun 22 ( Likely to be successful from the medical test history experience)

Thus to conclude, this is a good BUY for mid-long term.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论2

  • 推荐
  • 最新
empty
暂无评论